This filing contains no new pricing, financial, or regulatory information. The stock continues to trade on the original deal thesis. The next material catalyst will be the S-4 filing with full proxy/prospectus, after which Synaptics' shareholder vote and regulatory clearances will be the key milestones. Monitor for any antitrust scrutiny announcements or dissident shareholder activity in the interim.
Price Chart
Executive Summary
Onsemi filed a transcript of an internal all-hands meeting where CEO Hassane El-Khoury detailed the strategic rationale for the ~$7B all-stock acquisition of Synaptics, emphasizing the combination of onsemi's power/sensing leadership with Synaptics' edge AI compute platform to target the physical AI market. No new deal terms or material financial updates were disclosed; the filing is a routine internal communications update as the deal advances toward a mid-2027 close.
Key Financial Metrics
Key Facts
- CEO Hassane El-Khoury held an all-hands meeting on June 29, 2026 discussing the Synaptics acquisition.
- The acquisition is an all-stock deal valued at ~$7 billion enterprise value, with Synaptics stockholders receiving 1.350 onsemi shares per share.
- The deal is expected to close by mid-2027, subject to regulatory approvals and Synaptics stockholder vote.
- Post-synergies, the deal is expected to be accretive to non-GAAP EPS within 18 months of closing.
- Onsemi expects the combination to expand its total addressable market by $30 billion to $243 billion by 2030.
- The filing is a 425 communication — no changes to deal terms, financials, or timeline from the original announcement.
- The CEO reiterated that onsemi and Synaptics remain separate companies until close, and warned employees about cybersecurity risks during the transaction period.
Financial Impact
No new financial figures disclosed. Deal remains ~$7B enterprise value all-stock with ~19% premium to 10-day VWAP and $200M expected annual synergies. Expected to be accretive to non-GAAP EPS within 18 months post-synergies.
Risk Factors
- Regulatory approval risk — the deal faces potential antitrust review given combined semiconductor market presence.
- Synaptics shareholder vote risk — any large holder opposition could delay or derail the deal.
- Execution risk on $200M synergy target and 18-month accretion timeline.
- Cybersecurity risk during pre-close integration period, as acknowledged by CEO.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001140361-26-026823 |
| Document: 0001140361-26-026823-index-headers.html | 0001140361-26-026823 |
| Document: 0001140361-26-026823-index.html | 0001140361-26-026823 |
| Document: 0001140361-26-026823.txt | 0001140361-26-026823 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | S-4 | $74.21 $71.72 | ▼ −3.36% | ▼ −4.37% | $83.81 (+12.94%) |
Aug 13, 2026 7w ago | 425 | $81.56 $76.14 | ▼ −6.65% | ▼ −4.90% | $83.81 (+2.76%) |
Aug 13, 2026 7w ago | 8-K | $81.56 $76.14 | ▼ −6.65% | ▼ −4.90% | $83.81 (+2.76%) |
Aug 3, 2026 8w ago | 8-K | $80.78 $72.65 | ▼ −10.06% | ▼ −8.83% | $83.81 (+3.75%) |
Aug 3, 2026 8w ago | Press Release | $80.78 $72.65 | ▼ −10.06% | ▼ −8.83% | $83.81 (+3.75%) |
Jun 30, 2026 13w ago | 425 | $94.54 $89.04 | ▼ −5.82% | ▼ −4.79% | $83.81 (−11.35%) |
Jun 26, 2026 13w ago | 425 | $88.57 $86.81 | ▼ −1.99% | ▼ −1.71% | $83.81 (−5.37%) |
Jun 26, 2026 13w ago | 425 | $88.57 $86.81 | ▼ −1.99% | ▼ −1.71% | $83.81 (−5.37%) |
Jun 26, 2026 13w ago | 425 | $88.57 $86.81 | ▼ −1.99% | ▼ −1.71% | $83.81 (−5.37%) |
Jun 26, 2026 13w ago | 425 | $88.57 $86.81 | ▼ −1.99% | ▼ −1.71% | $83.81 (−5.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access